Leslie Jonart


Leslie joined Luminary Therapeutics in June 2022 from the University of Minnesota where she generated mouse models to reconstitute immune system effectively and efficiently in bone marrow translated mice, with a focus on thymic function and restoration of immune competence. Her research also explored specific pathways for overcoming both chemo- and immuno-resistance in novel model of Pre-B and Pre-T acute lymphoblastic leukemia with emphasis on the supportive microenvironments, primarily the central nervous system and bone marrow niches.